KRAS and non-small cell lung carcinoma: By using the Heterogeneity Score, we found that KRAS mutations were likely to be subclonal in the majority of NSCLC cases that we analyzed, whereas EGFR mutations in NSCLC seem to be in most cases clonal or at least represented in the majority of neoplastic cells.